To date, in no study has evaluated the role of Gremlin-1 in one of the micro- and macroangiopathic complications of diabetes, such as lower limb ulcers, been evaluated, which is why our results are innovative in this regard. The gene discussed is GREM1; the disease is diabetes mellitus.